about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsEfficacy and safety of celecoxib in chinese patients with ankylosing spondylitis: a 6-week randomized, double-blinded study with 6-week open-label extension treatmentEvaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.Management of arthropathy in inflammatory bowel diseases.Treat ankylosing spondylitis with methazolamide.Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study.Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis.An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab.Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study.Ankylosing spondylitis: recent breakthroughs in diagnosis and treatmentPerformance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis.How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?Health-related Quality of Life Assessment on 100 Tunisian Patients with Ankylosing Spondylitis using the SF-36 Survey.Exercise and inflammatory bowel diseaseCelecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control studyInfliximab in the treatment of ankylosing spondylitis.Increased expression of glucocorticoid receptor beta messenger RNA in patients with ankylosing spondylitis.Active axial spondyloarthritis: potential role of certolizumab pegol.Efficacy of an acquainted drug in the treatment of inflammatory low back pain: sulfasalazine under investigation.Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis.
P2860
Q22242050-E83CE194-4449-40B1-B34E-15B70FDB9A5BQ34705364-EB67F319-B0B5-4910-9423-470E3B270E05Q34808170-2C75B2B0-87DD-49A5-8489-0C967A5D345EQ35091366-E89ABCE2-E6F4-466F-928A-DEFAC0008120Q35097978-9E827047-87B1-4C1D-BFDC-7A5B3A6C6108Q35552253-1251649A-AD6C-455E-859F-3038BA0BECB4Q35554218-CB74295C-CE3A-4816-B63D-5E819A415DCCQ35638572-4E1EC42A-D309-4508-B748-4E45DE5EFAE2Q35708834-810FF186-D51E-4F64-96A3-8E0390F3B19BQ35940404-7F3FDD10-4393-46E8-99ED-FB407E04B9C8Q35953515-A06EDEF1-15FE-42E6-AA33-DB19AC3AB702Q36135031-C5394E48-857E-41B1-90DB-B9698BDD5196Q36143588-F50D8F45-046F-4F6C-9360-9B56AE5829DCQ36204136-208544CA-8DAC-4211-82AC-A74108CA2570Q36292652-421F9D1C-0B37-46CC-9421-F0738749EE79Q36454463-8CC8CEFD-6AAC-4C5C-AFD6-162DDE58CF8DQ37140211-8F6924A0-8CC8-4694-A54E-8ABAC5F14457Q37257008-1612BD9C-F469-46D4-B393-82538DA11923Q37290474-EE080AE5-1B6F-466D-8126-6CB10CE3CBDFQ37477058-54D682B8-61EA-4A16-81AF-77208ABD5D07Q38194547-4902524C-8303-418F-922A-BA95F2340B58Q41227254-364EB724-FE4A-4068-BB5E-12278ADF2F2FQ41822526-C4C400E9-5391-4F2F-AB5E-F7B4B32DC9B2
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Conventional treatments for ankylosing spondylitis.
@ast
Conventional treatments for ankylosing spondylitis.
@en
Conventional treatments for ankylosing spondylitis.
@nl
type
label
Conventional treatments for ankylosing spondylitis.
@ast
Conventional treatments for ankylosing spondylitis.
@en
Conventional treatments for ankylosing spondylitis.
@nl
prefLabel
Conventional treatments for ankylosing spondylitis.
@ast
Conventional treatments for ankylosing spondylitis.
@en
Conventional treatments for ankylosing spondylitis.
@nl
P2093
P2860
P1476
Conventional treatments for ankylosing spondylitis
@en
P2093
B Dijkmans
M Dougados
Sj van der Linden
W Maksymowych
P2860
P304
P356
10.1136/ARD.61.SUPPL_3.III40
P407
P478
61 Suppl 3
P577
2002-12-01T00:00:00Z